Carl Zeiss Meditec AG (0DHC.L)
- Previous Close
136.62 - Open
136.65 - Bid --
- Ask --
- Day's Range
135.90 - 136.65 - 52 Week Range
79.80 - 142.60 - Volume
31 - Avg. Volume
61,599 - Market Cap (intraday)
121.773M - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
0.46 - EPS (TTM)
2.96 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir4,823
Full Time Employees
September 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0DHC.L
Performance Overview: 0DHC.L
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0DHC.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0DHC.L
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
13.22%
Return on Assets (ttm)
--
Return on Equity (ttm)
13.24%
Revenue (ttm)
2.09B
Net Income Avi to Common (ttm)
276.8M
Diluted EPS (ttm)
2.96
Balance Sheet and Cash Flow
Total Cash (mrq)
10.6M
Total Debt/Equity (mrq)
7.16%
Levered Free Cash Flow (ttm)
--
Company Insights: 0DHC.L
0DHC.L does not have Company Insights